oxycodone has been researched along with Intestinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stubhaug, A | 1 |
| Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V | 1 |
1 review(s) available for oxycodone and Intestinal Diseases
| Article | Year |
|---|---|
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Topics: Constipation; Defecation; Female; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Piperidines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Receptors, Opioid, mu | 2018 |
1 other study(ies) available for oxycodone and Intestinal Diseases
| Article | Year |
|---|---|
Advances in understanding and treatment of opioid-induced-bowel-dysfunction, opioid-induced-constipation in particular: Nordic recommendations based on multi-specialist input.
Topics: Analgesics, Opioid; Constipation; Gastrointestinal Motility; Humans; Intestinal Diseases; Narcotic Antagonists; Oxycodone; Quality of Life; Quaternary Ammonium Compounds; Treatment Outcome | 2016 |